Predictors of 14-day mortality in patients with bloodstream infections caused by Enterobacteriaceae strains: a mathematical PK/PD analysis

Predictors of 14-day mortality in patients with bloodstream infections caused by Enterobacteriaceae strains: a mathematical PK/PD analysis

Bibliographic Details
Main Authors:	Luciana Azevedo Callefi, Eduardo A. Medeiros, Guilherme Henrique Campos Furtado
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000200021&lng=en&tlng=en

Similar Items

Impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by Enterobacteriaceae strains
by: Luciana Azevedo Callefi, et al.
Published: (2013-01-01)

Clinical and Mortality Risk Factors in Bloodstream Infections with Carbapenem-Resistant Enterobacteriaceae
by: Xiaopeng Li, et al.
Published: (2017-01-01)

Bloodstream Infections Caused By Carbapenemresistant Enterobacteriaceae: Risk Factors, Treatment and Effects on Mortality
by: Dilek BULUT, et al.
Published: (2020-09-01)

Impacto da introdução do sistema microbiológico automatizado Phoenix™ na evolução clínica das infecções de corrente sanguínea hospitalares por Enterobacteriaceae
by: Callefi, Luciana Azevedo [UNIFESP]
Published: (2015)

Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials.
by: Jason P Burnham, et al.
Published: (2017-01-01)

In vivo Pharmacokinetic and Pharmacodynamic (PK/PD) Modeling and Establishment of the PK/PD Cutoff of Florfenicol Against Pasteurella multocida in Ducks
by: Xia Xiao, et al.
Published: (2021-01-01)

Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets
by: Yu-Feng Zhou, et al.
Published: (2020-03-01)

The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials
by: Alicia Rodríguez-Gascón, et al.
Published: (2021-06-01)

PK-PD modelling of norfloxacin after oral administration in rabbits
by: B.H. Pavithra, et al.
Published: (2010-01-01)

PK-PD Analysis of Marbofloxacin against Streptococcus suis in Pigs
by: Zhixin Lei, et al.
Published: (2017-11-01)

Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea
by: Jung-wan Park, et al.
Published: (2019-03-01)

Bloodstream infections among children living in rural settings in Uganda and predictors of mortality outcome
by: J. Suvada, et al.
Published: (2014-04-01)

Research on the mechanism of drug–drug interaction between salvianolate injection and aspirin based on the metabolic enzyme and PK-PD model: study protocol for a PK-PD trial
by: Wantong Zhang, et al.
Published: (2018-09-01)

Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections
by: Matthias Karer, et al.
Published: (2020-05-01)

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
by: Pedro Ayau, et al.
Published: (2017-08-01)

Clinical and Bacterial Characteristics of Klebsiella pneumoniae Affecting 30-Day Mortality in Patients With Bloodstream Infection
by: Xingbing Wu, et al.
Published: (2021-09-01)

Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
by: Dai Y, et al.
Published: (2021-07-01)

Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.
by: Myrto Eleni Flokas, et al.
Published: (2017-01-01)

Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
by: Randall J. Mrsny, et al.
Published: (2021-07-01)

Increasing interest in PK and PD studies has many advantages for anesthesiologists
by: Young-Cheol Woo
Published: (2011-03-01)

Unraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic Proteins
by: Alison Smith, et al.
Published: (2016-01-01)

A PK-PD model of ketamine-induced high-frequency oscillations
by: Hartnack, Katharine, et al.
Published: (2017)

Risk factors and 30-day mortality for carbapenem-resistant Enterobacteriaceae infection, a case control study
by: Z.Y. Taye, et al.
Published: (2020-12-01)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
by: Yue-E Wu, et al.
Published: (2020-09-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
by: Maria Virginia Villegas, et al.
Published: (2016-01-01)

Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital
by: Chen Li, et al.
Published: (2019-01-01)

Risk factors for carbapenem-resistant K. pneumoniae bloodstream infection and predictors of mortality in Chinese paediatric patients
by: Ye Zhang, et al.
Published: (2018-05-01)

The epidemiology, antibiograms and predictors of mortality among critically-ill patients with central line-associated bloodstream infections
by: Shin-Huei Kuo, et al.
Published: (2018-06-01)

The PK/PD Integration and Resistance of Tilmicosin against <i>Mycoplasma hyopneumoniae</i>
by: Zilong Huang, et al.
Published: (2020-06-01)

PK/PD modeling of Ceftiofur Sodium against Haemophilus parasuis infection in pigs
by: Xiao-dong Li, et al.
Published: (2019-08-01)

Comparing Model Performance in Characterizing the PK/PD of the Anti‐Myostatin Antibody Domagrozumab
by: Abhinav Tiwari, et al.
Published: (2020-01-01)

Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
by: Yan Weng, et al.
Published: (2015-01-01)

Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance Prediction
by: Ijaz Ahmad, et al.
Published: (2016-01-01)

Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin and PK/PD Modeling against Escherichia coli in Pigs
by: Zhixin Lei, et al.
Published: (2017-08-01)

Are changes in the pharmacokinetic (PK) and pharmacodynamic (PD) properties of antipsychotics able to improve efficacy and safety?
by: Pani Luca
Published: (2008-04-01)

PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs
by: Zhixin Lei, et al.
Published: (2018-01-01)

A Cell-Level Systems PK-PD Model to Characterize In Vivo Efficacy of ADCs
by: Aman P. Singh, et al.
Published: (2019-02-01)

MYCOBACTERIUM TUBERCULOSIS DRUG RESISTANCE MUTATIONS AND UNDERSTANDING OF PK/PD: TREATMENT AND CARE IMPLICATIONS
by: S. K. Heysell, et al.
Published: (2018-12-01)

7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
by: Nick Daneman, et al.
Published: (2018-02-01)

Cannot write session to /tmp/vufind_sessions/sess_9po9i5tdadglh1k2rqiat1l04g